TickerFacts.

NeuroPace Inc (NPCE): Gross Profit

Annual figures by period end, from SEC filings.

$77.22M
Year ended 2025-12-31
+33.4%
3-year compound annual growth
+20.6%
5-year compound annual growth
2020-12-31: $30.27M2021-12-31: $33.44M2022-12-31: $32.49M2023-12-31: $48.12M2024-12-31: $59.09M2025-12-31: $77.22M$77.22M
2020-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$77.22M+30.7%2026-03-03, From 2025-01-01
2024-12-31$59.09M+22.8%2026-03-03, From 2024-01-01
2023-12-31$48.12M+48.1%2025-03-04, From 2023-01-01
2022-12-31$32.49M-2.8%2024-03-05, From 2022-01-01
2021-12-31$33.44M+10.4%2023-03-02, From 2021-01-01
2020-12-31$30.27Mn/a2022-03-10, From 2020-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
NeuroPace Inc (NPCE)2025-12-31$77.22M+30.7%
Beta Bionics, Inc. (BBNX)2025-12-31$55.54M+54.8%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$48.86M+101.8%
Pulmonx Corp (LUNG)2025-12-31$67.14M+8.3%
Anika Therapeutics, Inc. (ANIK)2025-12-31$63.81M-16.0%
Orasure Technologies Inc (OSUR)2025-12-31$48.20M-39.3%
Delcath Systems, Inc. (DCTH)2025-12-31$73.43M+136.8%
Iradimed Corp (IRMD)2025-12-31$64.32M+14.2%
TELA Bio, Inc. (TELA)2025-12-31$54.34M+16.9%

Compare NPCE, BBNX, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗